In vitro properties and experimental pathogenic effect of three strains of feline immunodeficiency viruses (FIV) isolated from cats with terminal disease
- PMID: 1377438
- PMCID: PMC7117354
- DOI: 10.1016/0378-1135(92)90140-o
In vitro properties and experimental pathogenic effect of three strains of feline immunodeficiency viruses (FIV) isolated from cats with terminal disease
Abstract
Three strains of virus isolated from peripheral blood mononuclear cells (PBMC) of sick cats were identified as feline immunodeficiency virus (FIV) on the basis of in vitro cytopathic effect, T-lymphotropism, ultrastructural morphology and magnesium-dependent reverse-transcriptase activity. The pathogenic properties of two isolates were studied in 13 experimentally infected cats. The primary phase of infection was characterised by a range of haematological (neutropenia, lymphopenia, presence of atypical lymphocytes) and clinical alterations (fever, various signs lasting several weeks, generalised lymphadenopathy persisting for several months) and specific seroconversion. A correlation between the inoculated dose of virus and the intensity and duration of clinical signs was observed. The primary phase was followed in the 10 surviving cats by a stage of asymptomatic seropositivity of undetermined duration but which has persisted for over 35 months for the earliest infections. Viruses reisolated several weeks or months after experimental infection retained the same in vitro properties as the initial isolates.
Similar articles
-
Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.Virology. 1994 Dec;205(2):546-53. doi: 10.1006/viro.1994.1677. Virology. 1994. PMID: 7975256
-
Isolation in Italy of feline immunodeficiency virus (FIV).Microbiologica. 1991 Apr;14(2):157-60. Microbiologica. 1991. PMID: 1649960
-
Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats.Vet Immunol Immunopathol. 2001 May 10;79(1-2):53-67. doi: 10.1016/s0165-2427(01)00252-5. Vet Immunol Immunopathol. 2001. PMID: 11356250
-
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.Clin Microbiol Rev. 1995 Jan;8(1):87-112. doi: 10.1128/CMR.8.1.87. Clin Microbiol Rev. 1995. PMID: 7704896 Free PMC article. Review.
-
Mucosal infection and vaccination against feline immunodeficiency virus.J Biotechnol. 1999 Aug 20;73(2-3):213-21. doi: 10.1016/s0168-1656(99)00139-x. J Biotechnol. 1999. PMID: 10486930 Review.
Cited by
-
Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.J Virol. 1998 Mar;72(3):2406-15. doi: 10.1128/JVI.72.3.2406-2415.1998. J Virol. 1998. PMID: 9499101 Free PMC article.
-
B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins.J Virol. 1993 Feb;67(2):664-72. doi: 10.1128/JVI.67.2.664-672.1993. J Virol. 1993. PMID: 7678301 Free PMC article.
-
Haematological disorders associated with feline retrovirus infections.Baillieres Clin Haematol. 1995 Mar;8(1):73-112. doi: 10.1016/s0950-3536(05)80233-1. Baillieres Clin Haematol. 1995. PMID: 7663052 Free PMC article. Review.
-
Retention of viral infectivity after extensive mutation of the highly conserved immunodominant domain of the feline immunodeficiency virus envelope.J Virol. 1997 Jun;71(6):4339-46. doi: 10.1128/JVI.71.6.4339-4346.1997. J Virol. 1997. PMID: 9151822 Free PMC article.
-
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns.J Virol. 1994 Apr;68(4):2230-8. doi: 10.1128/JVI.68.4.2230-2238.1994. J Virol. 1994. PMID: 8139008 Free PMC article.
References
-
- Alexander M., Robinson W.F., Mills J.N., Sherry C.R., Sherard E., Paterson A.J., Shaw S.E., Clark W.T., Holingsworth T. Isolation of Feline Immunodeficiency virus from three cats with lymphoma. Aust. Vet. Pract. 1989;19(2):93–97.
-
- Asjö B., Morfeldt-Manson L., Albert J., Biberfeld G., Karlsson A., Lidman K., Fenyö E.M. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. 1986;i:660–662. - PubMed
-
- Centers for Disease Control Classification system for human T-lymphotropic virus type III/lymphadenopathy associated virus infections H. HHWR. 1986;35:334–339. - PubMed
-
- Chappuis G., Tektoff J. Isolement et identification du virus syncitial félin. Ann. Microbiol. Inst. Pasteur. 1974;125A:371–386. - PubMed
-
- Cooper D.A., Maclean P., Finlayson R., Michelmore H.M., Gold J., Donovan B., Barnes T.G., Brooke P., Penny R. Acute aids retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985;i:537–540. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous